SLC2A3 and neoplasm: Earlier studies together with our mRNA expression analyses and a meta-analysis of hypoxia-inducible genes suggest that expression of SLC2A3/GLUT3 is induced in tumor cells and under control of many tumor-associated pathways including the HIF-pathway (15, 39).